CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ResuSciTec focuses on improving resuscitation outcomes for cardiac arrest patients through a new therapy called controlled whole body reperfusion. This approach utilizes specific biomarkers and an innovative diagnostic device to enhance survival rates and reduce neurological damage after prolonged cardiac arrest.
For decades there has been no significant improvement in resuscitation-therapy of patients suffering from cardiac arrest.
Only 3% survive out-of-hospital and only 18% survive in-hospital resuscitation.
The time-frame for a successful resuscitation is only about 3 to 5 minutes after cardiac arrest.
To increase this time-frame significantly ResuSciTec has developed a new therapeutical concept to induce a paradigmatic shift in resuscitation therapy.
This new concept called “controlled whole body re…
RESUSCITEC GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
